About Watson Debi
Form D filings for Perceive Biotherapeutics in 2023 list Watson Debi as director.
Watson Debi first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Watson Debi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Watson Debi works with at each company, as listed on that company's latest Form D.
Perceive Biotherapeutics, Inc. · Form D, Jan 13, 2023
AR
Anne Rubin
Executive officer and director
KM
Kirsten Macfarlane
CEO and director
CW
Cameron Wheeler
Director
RO
Randall Olson
Director
RJ
Robert Jackson
Director